제 2형 당뇨병 및 당뇨 합병증의 발생과 Peroxisome Proliferator-Activated Receptor-γ2 C161T 유전자 다형성과의 관계
The Association between Peroxisome Proliferator-Activated Receptor-Gamma C161T Polymorphism and Type 2 Diabetic Complications
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Objective : Peroxisome proliferator-activated receptor (PPAR)-gamma, a transcription factor in adipocyte differentiation, has important effects on insulin sensitivity, atherosclerosis, endothelial cell function and inflammation. Through these effects, PPAR-gamma2 might be involved with type 2 diabetes and vascular disease, including diabetic complications. Recently, it has been reported that the C161T polymorphism in the exon 6 of PPAR-gamma is associated with type 2 diabetes interacting with uncoupling protein 2 (UCP2) gene, and is associated with acute myocardial infarction. We studied the association of this polymorphism with type 2 diabetes and its complications, such as retinopathy, ischemic stroke, nephropathy and neuropathy in Korean non-diabetic and type 2 diabetic populations.Methods : Three hundred and thirty eight type 2 diabetic patients (retinopathy: 64, ischemic stroke: 67, nephropathy: 39 and neuropathy: 76) and 152 healthy matched control subjects were evaluated. The PPAR-gamma C161T polymorphism was analyzed by PCR-RFLP.Results : PPAR-gamma C161T genotype and allele frequency did not show significant differences between type 2 diabetic patients and healthy controls (T allele: 17.0 vs. 14.5, OR= 1.21, P=0.3188). In the analysis for diabetic complications, T allele in diabetic nephropathy was significantly higher than controls (P=0.0358). T allele in the ischemic stroke patients was also higher than healthy controls, although it had no significance (P=0.1375).Conclusions : These results suggest that the C161T polymorphism of the PPAR-gamma gene might be associated with diabetic nephropathy in type 2 diabetes.
참고문헌 (16)
- Altshuler D, "common PPARγPro12Ala polymorphism is associated with decreased risk of type 2 diabetes", 26(1), pp.76~80 (2000)
- Caramori ML, "The human peroxisome proliferator- activated receptorγ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes", 52(12), pp.3010~3013 (2003)
- Rhee EJ, "Effects of two common polymorphisms of peroxisome proliferator -activated receptor-gamma gene on metabolic syndrome", 37(1), pp.86~94 (2006)
- Liu Y, "PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression", 154(4), pp.718~724 (2007)
- Tavares V, "Effect of the peroxisome proliferator-activated receptor-gamma C161T polymorphism on lipid profile in Brazilian patients with Type 2 diabetes mellitus", 28(2), pp.129~136 (2008)
- Chao TH, "The 161TT genotype in the exon 6 of the peroxisome -proliferator-activated receptor gamma gene is associated with premature acute myocardial infarction and increased lipid peroxidation in habitual heavy smokers", 107(5), pp.461~466 (2007), Lond
- Song J, "Peroxisome proliferator-activated receptor gamma C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy", 64(5), pp.398~403 (2003)
- Caramori ML, "The human peroxisome proliferator- activated receptorγ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes", 52(12), pp.3010~3013 (2003)
- Issemann I, "Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990", pp.645~50
- Werman A, "Ligand- independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ (PPARγ). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin", 272(32), pp.20230~20235 (1997)
- Vidal-Puig AJ, "Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids", 99(10), pp.2416~2422 (1997)
- Lehmann JM, "An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptorγ (PPARγ)", 270(22), pp.12953~12956 (1995)
- Yen CJ, "Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ2 missense mutation", 241(2), pp.270~274 (1997)
- Jacob S, "The PPARγ2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients", 32(10), pp.413~416 (2000)
- Ringel J, "Pro12Ala missense mutation of the peroxisome proliferator activated receptor γ and diabetes mellitus", 254(2), pp.450~453 (1999)
- Ostgren CJ, "Peroxisome proliferator-activated receptor-γPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: skaraborg hypertension and diabetes project", 21(9), pp.1657~1662 (2003)